Vir Biotechnology, Inc.

VIR · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$222,947$241,576$848,631$347,815
Short-Term Investments$682,401$1,280,833$1,553,409$360,330
Receivables$0$0$0$773,079
Inventory$0$0$0$0
Other Curr. Assets$137,110$65,817$117,037$81,597
Total Curr. Assets$1,042,458$1,588,226$2,519,077$1,562,821
Property Plant & Equip (Net)$122,863$167,200$188,166$130,054
Goodwill$16,937$16,937$16,937$16,937
Intangibles$8,098$22,565$32,755$33,287
Long-Term Investments$190,015$105,275$23,927$201,388
Tax Assets$0$0$249,724$0
Other NC Assets$18,420$18,857-$228,498$9,781
Total NC Assets$356,333$330,834$283,011$391,447
Other Assets$22$0$0$0
Total Assets$1,398,813$1,919,060$2,802,088$1,954,268
Liabilities
Payables$5,081$6,334$6,422$6,521
Short-Term Debt$7,752$12,867$4,137$3,927
Tax Payable$0$149$15,228$6,217
Deferred Revenue$12,648$64,853$15,517$98,209
Other Curr. Liab.$94,181$91,204$469,725$226,368
Total Curr. Liab.$119,662$175,407$511,029$341,242
LT Debt$90,139$111,673$123,837$133,561
Deferred Rev, NC$0$1,526$53,207$3,815
Deferred Tax Liab, NC$0$0$3,253$18,439
Other NC Liab.$38,627$40,218$32,799$25,362
Total NC Liab.$128,766$153,417$213,096$181,177
Other Liabilities$0$0$0$0
Cap. Leases$97,891$124,540$127,974$137,488
Total Liabilities$248,428$328,824$724,125$522,419
Equity
Pref Stock$0$0$0$0
Common Stock$14$13$13$13
Retained Earnings-$759,784-$237,824$377,237-$138,600
AOCI-$1,717-$815-$9,122-$1,099
Other Equity$1,911,872$1,828,862$1,709,835$1,571,535
Total Equity$1,150,385$1,590,236$2,077,963$1,431,849
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,398,813$1,919,060$2,802,088$1,954,268
Net Debt-$125,056-$117,036-$720,657-$210,327